首页 | 本学科首页   官方微博 | 高级检索  
     

异基因造血干细胞移植后侵袭性真菌感染及其危险因素分析
引用本文:王志永,姜尔烈,张平,王华,包宇实,王玫,冯四洲,韩明哲. 异基因造血干细胞移植后侵袭性真菌感染及其危险因素分析[J]. 中国实验血液学杂志, 2008, 16(3): 618-622
作者姓名:王志永  姜尔烈  张平  王华  包宇实  王玫  冯四洲  韩明哲
作者单位:中国医学科学院、中国协和医科大学血液学研究所、血液病医院,天津,300020
摘    要:本研究分析异基因造血干细胞移植(allo—HSCT)后患者侵袭性真菌感染(IFI)的发生及其高危因素。选择自2000年1月至2007年3月在我院行allo—HSCT患者180例,随访至2007年10月31日,用Kaplan—Meier和Cox回归模型方法,分析了IFI的发生率及其相关的危险因素。结果表明,35例(19、5%)患者在HSCT后发生了IFI,确诊1例,临床诊断34例;其中曲霉菌感染18例(51、4%),念珠菌感染17例(48.6%)。IFI组1年的存活率为34.3%.无IFI组1年的存活率为53.8%,存在显著性差异。在单因素分析中,与IFI的发生率增加有关的因素包括移植前真菌定植或感染、非血缘供者allo—PBHSC或allo—BMHSC移植、急性GVHD发生、广泛性慢性GVHD、应用甲基泼尼松龙。在多因素分析时,非血缘供者异基因外周血或骨髓干细胞移植、急性GVHD发生及移植前真菌感染或定植使IFI发生危险增加(RR分别为:1.589、2、399、1.410)。结论:IFI是allo—HSCT的常见并发症,也是主要致死原因之一,对移植前真菌感染或定植、非血缘供者allo-PBHSC或allo—BMHSC移植及发生急性GVHD的高危患者有必要早期采取干预性治疗。

关 键 词:造血干细胞移植  侵袭性真菌感染  危险因素
文章编号:1009-2137(2008)03-0618-05
修稿时间:2008-02-18

Invasive Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation and Related Risk Factors
WANG Zhi-Yong,JIANG Er-Lie,ZHANG Ping,WANG Hua,BAO Yu-Shi,WANG Mei,FENG Si-Zhou,HAN Ming-Zhe. Invasive Fungal Infections after Allogeneic Hematopoietic Stem Cell Transplantation and Related Risk Factors[J]. Journal of experimental hematology, 2008, 16(3): 618-622
Authors:WANG Zhi-Yong  JIANG Er-Lie  ZHANG Ping  WANG Hua  BAO Yu-Shi  WANG Mei  FENG Si-Zhou  HAN Ming-Zhe
Affiliation:Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
Abstract:In order to analyze the incidence and high-risk factors of invasive fungal infections among recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), 180 cases of allo-HSCT were enrolled in this study. The incidence and risk factors of IFI were analyzed by method of Kaplan-Meier and Cox regression model. The results showed that an incidence of IFI in 35 cases (19.5%) were detected, with 1 case proven and 34 cases probably diagnosed, which was composed of 18 cases (51.4%) of aspergillosis and 17 cases (48.6%) of candidosis. There was significant difference in one-year overall survival rate between patients with (34.3%) or without (53.8%) IFI. In univariate analysis, risk factors of IFI included: pretransplant fungal infection or colonization, unrelated donor (peripheral blood or bone marrow stem cell) transplantation, acute GVHD, extensive chronic GVHD and the use of methylprednisolone. In multi-variate analysis, the following risk factors of IFI were found:unrelated donor for allogeneic peripheral blood or bone marrow stem cell transplantation, acute GVHD and pretransplant fungal infection or colonization acute GVHD (RR: 2.399, 1.589, and 0.836). It is concluded that IFI is a frequent complication and one of the leading causes of mortality among recipients of allo-HSCT. As for patients with higher risk of IFI, early interventions should be taken.
Keywords:hematopoietic stem cell transplantation  invasive fungal infection  risk factors
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号